Table 1. Clinical Characteristics of Study Population.
| Asymptomatic (n = 12) | Symptomatic (n = 22) | TIA (n = 12) | Stroke (n = 10) | |
| Age, y | 73±2 | 71±2 | 69±3 | 72±3 |
| Sex M/F, n | 8/4 | 13/9 | 8/4 | 5/5 |
| BMI, kg/m2 | 30.1±2.0 | 28.6±1.1 | 28.5±1.2 | 28.6±1.9 |
| Systolic blood pressure, mm Hg | 132.3±4.3 | 140.9±4.5 | 140.2±5.9 | 141.7±7.3 |
| Diastolic blood pressure, mm Hg | 68.4±2.2 | 77.2±1.7* | 79.4±2.0* | 74.7±2.7 |
| Medical History | ||||
| CAD, n (%) | 9 (75) | 5 (22)* | 3 (25)* | 2 (20)* |
| Hypertension, n (%) | 11 (92) | 16 (73) | 9 (75) | 7 (70) |
| Diabetes, n (%) | 2 (17) | 3 (14) | 2 (17) | 1 (10) |
| Smoking History, n (%) | 7 (58) | 17 (77) | 9 (75) | 8 (80) |
| Hypercholesterolemia, n (%) | 9 (75) | 13 (59) | 8 (67) | 5 (50) |
| Lipid Profile | ||||
| Total Cholesterol, mg/dL | 189.4±10.4 | 187.1±7.5 | 183.6±8.0 | 192.0±14.8 |
| LDL, mg/dL | 109.2±7.4 | 107.3±7.5 | 103.4±9.4 | 112.9±13.0 |
| HDL, mg/dL | 44.4±3.3 | 42.9±2.4 | 41.5±3.5 | 44.9±3.1 |
| Medications | ||||
| Statins, n (%) | 7 (58) | 7 (32) | 4 (33) | 3 (30) |
| ACE-Inhibitors, n (%) | 3 (25) | 4 (18) | 4 (33) | 0 (0) |
| ARBs, n (%) | 1( 8) | 2 (9) | 1 (8) | 1 (10) |
| Aspirin, n (%) | 10 (83) | 19 (86) | 12 (100) | 7 (70) |
| Days since last event | 0±0 | 79±21 | 71±27 | 85±35 |
BMI indicates body mass index; CAD indicates coronary artery disease; LDL indicates low density lipoprotein; HDL indicates high density lipoprotein; ARB indicates angiotensin II receptor blocker; Values are expressed as mean±SEM for continuous variables;
*p<0.05 vs. asymptomatic.